Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2006, p. 3160-3161, Vol. 50, No. 9
0066-4804/06/$08.00+0 doi:10.1128/AAC.00563-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Escape of Candida from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for ß-1,6-Glucan Synthesis Inhibition by Caspofungin
David A. Stevens,1*
Masayuki Ichinomiya,2,
Yukako Koshi,2 and
Hiroyuki Horiuchi2
Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128-2699, and Stanford University, Stanford, California 94305,1
Department of Biotechnology, University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan2
Received 7 May 2006/
Returned for modification 13 June 2006/
Accepted 5 July 2006

ABSTRACT
Concentrations above the MIC of caspofungin allow growth of
some
Candida isolates. A strain demonstrating paradoxical growth
was grown in the presence and absence of caspofungin, and the
cell wall content was analyzed. ß-1,3-Glucan declined
81% in the presence of caspofungin, as expected. ß-1,6-Glucan
declined 73%. Chitin increased 898%, demonstrating a mechanism
for paradoxical growtha rapid shift in the key polymer.

TEXT
The inhibition of fungi by caspofungin, an echinocandin, is
attributed to interference with synthesis of the cell wall polymer
ß-1,3-glucan. The principal target of caspofungin
is the protein Fks1, and binding leads to reduced activity of
the enzyme glucan synthase and reduced formation of and extrusion
of the glucan polymer through the cell membrane and into the
wall (
5). With
Candida species, the result is a low MIC (typically
<0.5 µg/ml), and fungicidal activity at or very close
to the MIC (
5). However, many isolates of
Candida are able to
grow at some caspofungin concentrations higher than the MIC
(
11), which we have termed the paradoxical effect. The frequency
of this phenomenon is 21% of 76
Candida albicans isolates (
4;
D. A. Stevens, unpublished). The cause of the paradoxical growth
was not mutations in resistance-associated regions of the ß-1,3-glucan
synthase complex, selection of a resistant subpopulation, or
destruction of the drug, but the mechanism remains unelucidated
(
12). We proposed that the gene(s) is promptly activated by
the presence of high caspofungin concentrations (
11,
12), and
speculation on the mechanism included "compensatory upregulation
of synthesis of another wall component" (
11).
A stimulus for the present studies was our observation (10) that an echinocandin and a chitin synthesis inhibitor acted in a highly synergistic manner in vitro, which was corroborated in vivo (3). This suggests that if one cell wall polymer is inhibited, the other might compensate, and that if both were blocked, the fungus would be defenseless.
The present studies examined cell wall content in an isolate (C. albicans strain 95-68) that we reported previously (11) as showing a prominent paradoxical effect. The paradoxical growth was compared to that in the absence of caspofungin.
Growth in the presence of high (12.5 µg/ml) concentrations of caspofungin and its absence was as described previously (11, 12). The cells were disrupted by >150 cycles of freezing and thawing followed by glass bead bombardment until no viable cells could be demonstrated by subculture, and the disruption was verified by microscopy (12). The cell walls were separated from cytosol and glass beads by centrifugation (12), and the walls were dried, lyophilized, and frozen. Two separate preparations were made, 7 months apart, in the presence and absence of caspofungin. Each preparation was studied, two or three 30-mg samples of each culture condition in each time period, and each sample was studied in duplicate. Student's t test was used for comparison of caspofungin with no caspofungin for each carbohydrate group analyzed.
Glucan and chitin contents were determined by published methods (2, 9) with several modifications. Each sample analyzed was a 10-mg quadruplicate sample. Lyophilized cell wall (
20 mg) was extracted three times with 500 µl of 3% NaOH at 75°C for 1 h. The supernatants from NaOH extraction were added to 2 volumes of ethanol and incubated at 20°C for >1 h. After centrifugation at 15,000 rpm for 5 min at 4°C, precipitates were dissolved in water, and hexose contents were measured by the borosulfuric acid method (1) (alkali-soluble glucans). The NaOH extraction pellets were washed once with 100 mM Tris-HCl and 10 mM Tris-HCl (pH 7.5). The pellets were digested with 4 mg/ml Zymolyase 100T (prepared from Arthrobacter luteus, primarily ß-1,3-glucan hydrolase; Seikagaku Corporation, Tokyo, Japan) in 10 mM Tris-HCl overnight at 37°C and centrifuged for 10 min at 15,000 rpm at 4°C. The supernatants were divided into two portions. One was used for measurement of hexose content (alkali-insoluble ß-1,3- plus 1,6-glucans). The other was dialyzed against distilled water using a Spectra/Por membrane with a molecular weight exclusion of 6,000 to 8,000 (Spectrum Medical Industries, Inc., Rancho Dominguez, CA), and hexose contents were measured (alkali-insoluble ß-1,6-glucans). Zymolyase-insoluble pellets were washed once with 10 mM Tris-HCl and water. The pellets were suspended in water and divided into two portions. One was used for measurement of hexose content (Zymolyase-indigestible pellets). The other was centrifuged, and the pellet was used for measurement of hexosamine content to determine chitin concentrations. The pellets were digested in 6 N HCl at 100°C for 6 h. After evaporation, the pellets were suspended in water, and the hexosamine content was measured by colorimetry (13). D-Glucosamine (0 to 200 µg/ml) (Wako Pure Chemical Industries, Japan) was used as a standard.
The results (means of duplicate results/experiment; two experiments/sample, two samples/two independent preparations) are shown in Table 1. They show a highly significant effect of caspofungin on the cell wall content of all hexoses, including glucans, and chitin. The glucan content is significantly depressed by caspofungin, and the chitin content is significantly upregulated. The depression of ß-1,3- and ß-1,6-glucan levels and increase of chitin levels by caspofungin was not quite as marked in the second preparation run, though the differences were highly significant with respect to caspofungin effect in the two independent runs.
These results provide an explanation for the paradoxical effect
described previously (
11): namely, that those isolates which
are capable of surviving in caspofungin at high concentrations
do so by compensatorily increasing their cell wall chitin content.
At these concentrations the glucan synthesis inhibition effect
of caspofungin remains highly significant. This also confirms
findings (
12) with the enzyme itself that upregulation of glucan
synthase is not the mechanism of escape. Studies with
C. albicans involving only brief exposure to caspofungin (
15) confirmed
earlier observations that there is upregulation of the intracellular
protein kinase C cell wall integrity pathway. That compensatory
chitin synthesis occurs in paradoxical growth is consistent
with inferences from gene interaction studies of
Saccharomyces cerevisiae of what occurs in the usual caspofungin growth inhibition
(
8).
We also demonstrate that caspofungin also inhibits synthesis of ß-1,6-glucan, as well as ß-1,3-glucan. ß-1,6-Glucan synthesis and incorporation proceed through several enzyme steps (14), and Fks1p inhibition would affect a late stage. Our finding is consistent with suggestions from gene disruption studies (6) and studies of glucose linkages in Cryptococcus neoformans (7) and broadens our understanding of caspofungin antifungal mechanisms.

ACKNOWLEDGMENTS
We thank David W. Denning, Claude P. Selitrennikoff, and Cameron
Douglas for helpful suggestions and Marife Martinez for assistance.

FOOTNOTES
* Corresponding author. Mailing address: Santa Clara Valley Medical Center, 751 South Bascom Ave., San Jose, CA 95128-2699. Phone: (408) 885-4313. Fax: (408) 885-4306. E-mail:
stevens{at}stanford.edu.

Present address: National Food Research Institute, 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8642, Japan. 

REFERENCES
1 - Badin, J., C. Jackson, and M. Schubert. 1953. Improved method for determination of plasma polysaccharides with tryptophan. Proc. Soc. Exp. Biol. Med. 84:288-291.[CrossRef]
2 - Boon, C., S. S. Sommer, A. Hensel, and H. Bussey. 1990. Yeast KRE genes provide evidence for a pathway of cell wall ß-glucan assembly. J. Cell Biol. 110:1833-1843.[Abstract/Free Full Text]
3 - Capilla Luque, J., K. V. Clemons, and D. A. Stevens. 2003. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob. Agents Chemother. 47:1452-1455.[Abstract/Free Full Text]
4 - Clemons, K. V., M. Espiritu, R. Parmar, and D. A. Stevens. 2006. Assessment of paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob. Agents Chemother. 50:1293-1297.[Abstract/Free Full Text]
5 - Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457.[CrossRef][Medline]
6 - Dijkgraaf, G. J. P., M. Abe, Y. Ohya, and H. Bussey. 2002. Mutations in Fks1p affect the cell wall content of ß-1,3 and ß-1,6-glucan in Saccharomyces cerevisiae. Yeast 19:671-690.[CrossRef][Medline]
7 - Feldmesser, M., Y. Kress, A. Mednick, and A. Casadevall. 2000. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J. Infect. Dis. 182:1791-1795.[CrossRef][Medline]
8 - Lesage, G., A.-M. Sdicu, P. Menard, J. Shapiro, S. Hussein, and H. Bussey. 2004. Analysis of ß-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics 167:35-49.[Abstract/Free Full Text]
9 - Popolo, L., D. Gilardelli, P. Bonfante, and M. Vai. 1997. Increase in chitin as an essential response to defects in assembly of cell wall polymers in the ggp1
mutant of Saccharomyces cerevisiae. J. Bacteriol. 179:463-469.[Abstract/Free Full Text] 10 - Stevens, D. A. 2000. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob. Agents Chemother. 44:2547-2548.[Abstract/Free Full Text]
11 - Stevens, D. A., M. Espiritu, and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48:3407-3411.[Abstract/Free Full Text]
12 - Stevens, D. A., T. C. White, D. S. Perlin, and C. P. Selitrennikoff. 2005. Studies of the paradoxical effect of caspofungin at high drug concentrations. Diagn. Microbiol. Infect. Dis. 51:173-178.[CrossRef][Medline]
13 - Tracey, M. V. 1956. Chitin, p.264-274 In P. Peach and M. V. Tracey (ed.), Modern methods of plant analysis, vol. II. Springer-Verlag Publications, Berlin, Germany.
14 - Umeyama, T., A. Kaneko, H. Watanabe, A. Hirai, Y. Uehara, M. Niimi, and M. Azuma. 2006. Deletion of the CaBIG1 gene reduces ß-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans. Infect. Immun. 74:2373-2381.[Abstract/Free Full Text]
15 - Wiederhold, N. P., D. P. Kontoyiannis, R. A. Prince, and R. E. Lewis. 2005. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother. 49:5146-5148.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, September 2006, p. 3160-3161, Vol. 50, No. 9
0066-4804/06/$08.00+0 doi:10.1128/AAC.00563-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ferreira, J. A. G., Carr, J. H., Starling, C. E. F., de Resende, M. A., Donlan, R. M.
(2009). Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates. Antimicrob. Agents Chemother.
53: 4377-4384
[Abstract]
[Full Text]
-
Moreno-Ruiz, E., Ortu, G., de Groot, P. W. J., Cottier, F., Loussert, C., Prevost, M.-C., de Koster, C., Klis, F. M., Goyard, S., d'Enfert, C.
(2009). The GPI-modified proteins Pga59 and Pga62 of Candida albicans are required for cell wall integrity. Microbiology
155: 2004-2020
[Abstract]
[Full Text]
-
Aimanianda, V., Clavaud, C., Simenel, C., Fontaine, T., Delepierre, M., Latge, J.-P.
(2009). Cell Wall {beta}-(1,6)-Glucan of Saccharomyces cerevisiae: STRUCTURAL CHARACTERIZATION AND IN SITU SYNTHESIS. J. Biol. Chem.
284: 13401-13412
[Abstract]
[Full Text]
-
Fortwendel, J. R., Juvvadi, P. R., Pinchai, N., Perfect, B. Z., Alspaugh, J. A., Perfect, J. R., Steinbach, W. J.
(2009). Differential Effects of Inhibiting Chitin and 1,3-{beta}-D-Glucan Synthesis in Ras and Calcineurin Mutants of Aspergillus fumigatus. Antimicrob. Agents Chemother.
53: 476-482
[Abstract]
[Full Text]
-
Varga, I., Soczo, G., Kardos, G., Majoros, L.
(2008). Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3. J Antimicrob Chemother
62: 149-152
[Abstract]
[Full Text]
-
Cramer, R. A. Jr., Perfect, B. Z., Pinchai, N., Park, S., Perlin, D. S., Asfaw, Y. G., Heitman, J., Perfect, J. R., Steinbach, W. J.
(2008). Calcineurin Target CrzA Regulates Conidial Germination, Hyphal Growth, and Pathogenesis of Aspergillus fumigatus. Eukaryot Cell
7: 1085-1097
[Abstract]
[Full Text]
-
Cowen, L. E., Steinbach, W. J.
(2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell
7: 747-764
[Full Text]
-
Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., Wiederhold, N. P.
(2008). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrob. Agents Chemother.
52: 1144-1146
[Abstract]
[Full Text]
-
Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J.
(2008). Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia. Antimicrob. Agents Chemother.
52: 321-328
[Abstract]
[Full Text]
-
Pasquale, T., Tomada, J. R., Ghannoun, M., Dipersio, J., Bonilla, H.
(2008). Emergence of Candida tropicalis resistant to caspofungin. J Antimicrob Chemother
61: 219-219
[Full Text]
-
Soczo, G., Kardos, G., Varga, I., Kelentey, B., Gesztelyi, R., Majoros, L.
(2007). In Vitro Study of Candida tropicalis Isolates Exhibiting Paradoxical Growth in the Presence of High Concentrations of Caspofungin. Antimicrob. Agents Chemother.
51: 4474-4476
[Abstract]
[Full Text]
-
Plummer, R., Bodkin, J., Power, D., Pantarat, N., Bubb, W. A., Kuchel, P. W., Sorrell, T. C.
(2007). Effect of Caspofungin on Metabolite Profiles of Aspergillus Species Determined by Nuclear Magnetic Resonance Spectroscopy. Antimicrob. Agents Chemother.
51: 4077-4084
[Abstract]
[Full Text]
-
Melo, A. S., Colombo, A. L., Arthington-Skaggs, B. A.
(2007). Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species. Antimicrob. Agents Chemother.
51: 3081-3088
[Abstract]
[Full Text]
-
Steinbach, W. J., Cramer, R. A. Jr., Perfect, B. Z., Henn, C., Nielsen, K., Heitman, J., Perfect, J. R.
(2007). Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against Aspergillus fumigatus. Antimicrob. Agents Chemother.
51: 2979-2981
[Abstract]
[Full Text]
-
Chamilos, G., Lewis, R. E., Albert, N., Kontoyiannis, D. P.
(2007). Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences. Antimicrob. Agents Chemother.
51: 2257-2259
[Abstract]
[Full Text]
-
Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J.
(2007). Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species. Antimicrob. Agents Chemother.
51: 881-887
[Abstract]
[Full Text]